We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+5.3%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.53B
AUM Growth
+$159M
(+3%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
20.92%
Holding
797
New
64
Increased
251
Reduced
262
Closed
82
Avg Time Held
1.1
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$42M |
| 2 |
CF Industries
CF
|
+$41.4M |
| 3 |
BEAV
B/E Aerospace Inc
BEAV
|
+$36.2M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$33.3M |
| 5 |
Sunoco
SUN
|
+$29.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$55.7M |
| 2 |
ITC
ITC HOLDINGS CORP
ITC
|
+$38.9M |
| 3 |
AGN
Allergan Inc
AGN
|
+$38.3M |
| 4 |
Accenture
ACN
|
+$37.2M |
| 5 |
Tesla
TSLA
|
+$35.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.43% |
| 2 | Financials | 16.55% |
| 3 | Consumer Discretionary | 12.19% |
| 4 | Industrials | 12.01% |
| 5 | Technology | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
DELISTED
ENVESTNET, INC.
ENV
| $882K | 0.02% |
15,721
+1,804
| +13% | +$96.3K |
2013 Q2
7 quarters
|
|
302
Amgen
AMGN
$234B
| $879K | 0.02% |
5,496
+115
| +2% | +$18.1K |
2013 Q2
7 quarters
|
|
303
DELISTED
HCC INSURANCES HOLDINGS INC
HCC
| $854K | 0.02% |
15,061
-1,309
| -8% | -$72.5K |
2013 Q2
7 quarters
|
|
304
United Therapeutics
UTHR
$22.9B
| $848K | 0.02% |
+4,920
| New | +$750K |
2015 Q1
0 quarters
|
|
305
TSMC
TSM
$2.14T
| $843K | 0.02% |
35,908
-1,570
| -4% | -$37K |
2014 Q1
4 quarters
|
|
306
Franco-Nevada
FNV
$47B
| $833K | 0.02% |
17,170
-565
| -3% | -$29.4K |
2014 Q1
4 quarters
|
|
307
Trex
TREX
$4.66B
| $833K | 0.02% |
61,088
+8,680
| +17% | +$100K |
2013 Q2
7 quarters
|
|
308
Teva Pharmaceutical Industries Limited
TEVA
$48.4B
| $823K | 0.01% |
13,211
-297
| -2% | -$17.3K |
2013 Q2
7 quarters
|
|
|
BSTC
309
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $822K | 0.01% |
20,987
+3,071
| +17% | +$120K |
2014 Q1
4 quarters
|
|
310
Trimble
TRMB
$13.9B
| $821K | 0.01% |
32,574
-1,305
| -4% | -$33.5K |
2013 Q2
7 quarters
|
|
|
IMPV
311
DELISTED
Imperva, Inc.
IMPV
| $809K | 0.01% |
18,953
+14,003
| +283% | +$623K |
2014 Q4
1 quarter
|
|
312
Lowe's Companies
LOW
$111B
| $799K | 0.01% |
10,742
-675
| -6% | -$48.4K |
2013 Q2
7 quarters
|
|
313
DELISTED
Spirit Airlines, Inc.
SAVE
| $797K | 0.01% |
10,308
+4,049
| +65% | +$311K |
2014 Q3
2 quarters
|
|
314
Bank of America
BAC
$358B
| $770K | 0.01% |
50,003
-2,572
| -5% | -$41.3K |
2013 Q2
7 quarters
|
|
315
Methanex
MEOH
$5.03B
| $754K | 0.01% |
14,075
-589
| -4% | -$29.5K |
2014 Q1
4 quarters
|
|
316
DELISTED
Dominion Diamond Corporation
DDC
| $750K | 0.01% |
43,900
-2,200
| -5% | -$37.1K |
2014 Q1
4 quarters
|
|
317
DELISTED
PUBLIC STORAGE DEPOSITORY SH REPSTG 1/1000TH PFD SER R
PSA.PRR
| $722K | 0.01% |
27,215
| – | – |
2014 Q3
2 quarters
|
|
318
WisdomTree
WT
$3.24B
| $715K | 0.01% |
+33,298
| New | +$622K |
2015 Q1
0 quarters
|
|
319
Simon Property Group
SPG
$66.5B
| $707K | 0.01% |
3,612
-242
| -6% | -$46.9K |
2013 Q2
7 quarters
|
|
320
Fidelity National Information Services
FIS
$18.6B
| $703K | 0.01% |
10,325
+4,824
| +88% | +$315K |
2014 Q4
1 quarter
|
|
321
BP
BP
$129B
| $701K | 0.01% |
21,591
-143
| -0.7% | -$4.68K |
2013 Q2
7 quarters
|
|
322
Celanese
CE
$5.21B
| $700K | 0.01% |
12,539
+170
| +1% | +$9.62K |
2013 Q3
6 quarters
|
|
323
EOG Resources
EOG
$82.9B
| $699K | 0.01% |
7,620
-3,668
| -32% | -$331K |
2013 Q2
7 quarters
|
|
324
Fomento Económico Mexicano
FMX
$43.1B
| $684K | 0.01% |
7,311
+876
| +14% | +$78.1K |
2014 Q1
4 quarters
|
|
|
GRUB
325
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $674K | 0.01% |
+7,423
| New | +$598K |
2015 Q1
0 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, Geneva Advisors held 797 positions worth $5.53B, up 3% from $5.37B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geneva Advisors's Q1 2015 filing shows 64 new, 251 increased, 262 reduced and 82 closed positions. Its largest new stake was Ulta Beauty: 303,437 shares worth $45.8M. The largest sale was Johnson & Johnson, an estimated $55.7M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geneva Advisors's largest Q1 2015 buy was Ulta Beauty: 303,437 shares worth $45.8M.
- Geneva Advisors added most to CF Industries in Q1 2015, an estimated $41.4M increase.
- Geneva Advisors's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $55.7M.
- Geneva Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $38.3M.
- Geneva Advisors's ten largest holdings make up 21% of its $5.53B portfolio in Q1 2015.
- Geneva Advisors opened 64 new positions and closed 82 in Q1 2015.
- Geneva Advisors's portfolio value rose 3% quarter-over-quarter to $5.53B.
Based on Geneva Advisors's 13F filing for Q1 2015, filed 5 May 2015.